2025-01-01 2025-12-31 false No description of principal activity Acting Office - Tax and Accounts 1.0 11091795 bus:FullAccounts 2025-01-01 2025-12-31 11091795 bus:Micro-entities 2025-01-01 2025-12-31 11091795 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 11091795 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 11091795 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11091795 2025-01-01 2025-12-31 11091795 2025-12-31 11091795 bus:RegisteredOffice 2025-01-01 2025-12-31 11091795 core:WithinOneYear 2025-12-31 11091795 core:AfterOneYear 2025-12-31 11091795 2024-01-01 11091795 bus:Director1 2025-01-01 2025-12-31 11091795 bus:Director1 2025-12-31 11091795 bus:Director1 2024-01-01 2024-12-31 11091795 bus:CompanySecretary1 2025-01-01 2025-12-31 11091795 bus:LeadAgentIfApplicable 2025-01-01 2025-12-31 11091795 2024-01-01 2024-12-31 11091795 2024-12-31 11091795 core:WithinOneYear 2024-12-31 11091795 core:AfterOneYear 2024-12-31 11091795 bus:EntityAccountantsOrAuditors 2024-01-01 2024-12-31 11091795 core:CostValuation core:Non-currentFinancialInstruments 2025-12-31 11091795 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 11091795 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-12-31 11091795 core:Non-currentFinancialInstruments 2025-12-31 11091795 core:Non-currentFinancialInstruments 2024-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11091795
England and Wales

 

 

 

IREPLACEPARTS LTD


Unaudited Financial Statements
 


Period of accounts

Start date : 01 January 2025

End date : 31 December 2025
 
 
2025
£
    2024
£
 
Current assets 64,071  82,934 
Creditors: amount falling due within one year (54,892) (82,901)
Net current assets/(liabilities) 9,179  33 
Total assets less current liabilities 9,179  33 
Net assets/(liabilities) 9,179  33 
 
Capital and reserves 9,179  33 
 



Notes to the Accounts
Statutory Information
Ireplaceparts Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number 11091795, registration address 10a High Street, Chislehurst, Kent, BR7 5AN, England.

The presentation currency is £ sterling.
1.

Accounting Policies

Basis of accounting
The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).
2.

Average number of employees

Average number of employees during the year was 1 (2024: 1).

Director's Responsibilities:
  1. For the year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
  2. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Signed on behalf of the board of directors:


---------------------------------------------
Thomas Rhodes
Director

Date approved: 21 September 2026
1